A Single Dose of Pembrolizumab in HIV-Infected People
Stopped Difficulty with subject recruitment
Conditions
- Human Immunodeficiency Virus
Interventions
- OTHER: Placebo
- DRUG: Pembrolizumab
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators